BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 9092862)

  • 1. Should endolymphatic sac tumors be considered part of the von Hippel-Lindau complex? Pathology case report.
    Tibbs RE; Bowles AP; Raila FA; Fratkin JD; Hutchins JB
    Neurosurgery; 1997 Apr; 40(4):848-55; discussion 855. PubMed ID: 9092862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endolymphatic sac tumor with von Hippel-Lindau disease: report of a case with atypical pathology of endolymphatic sac tumor.
    Yang X; Liu XS; Fang Y; Zhang XH; Zhang YK
    Int J Clin Exp Pathol; 2014; 7(5):2609-14. PubMed ID: 24966975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endolymphatic sac tumors in patients with and without von Hippel-Lindau disease: the role of genetic mutation, von Hippel-Lindau protein, and hypoxia inducible factor-1alpha expression.
    Jensen RL; Gillespie D; House P; Layfield L; Shelton C
    J Neurosurg; 2004 Mar; 100(3):488-97. PubMed ID: 15035285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatic von Hippel-Lindau gene mutations detected in sporadic endolymphatic sac tumors.
    Vortmeyer AO; Huang SC; Koch CA; Governale L; Dickerman RD; McKeever PE; Oldfield EH; Zhuang Z
    Cancer Res; 2000 Nov; 60(21):5963-5. PubMed ID: 11085513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endolymphatic sac tumor (aggressive papillary tumor of middle ear and temporal bone): report of two cases with analysis of the VHL gene.
    Skalova A; Síma R; Bohus P; Curík R; Lukás J; Michal M
    Pathol Res Pract; 2008; 204(8):599-606. PubMed ID: 18423895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VHL gene inactivation in an endolymphatic sac tumor associated with von Hippel-Lindau disease.
    Kawahara N; Kume H; Ueki K; Mishima K; Sasaki T; Kirino T
    Neurology; 1999 Jul; 53(1):208-10. PubMed ID: 10408561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Endolymphatic sac tumor with von Hippel-Lindau disease: report of two cases with testing of von Hippel-Lindau gene].
    Su Y; Shen WD; Wang CC; Han WJ; Liu J; Hou ZH; Song ZG; Huang DL; Han DY; Yang SM
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Nov; 48(11):913-8. PubMed ID: 24444636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meningioma showing VHL gene inactivation in a patient with von Hippel-Lindau disease.
    Kanno H; Yamamoto I; Yoshida M; Kitamura H
    Neurology; 2003 Apr; 60(7):1197-9. PubMed ID: 12682336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of heterozygosity and somatic mutations of the VHL tumor suppressor gene in sporadic cerebellar hemangioblastomas.
    Lee JY; Dong SM; Park WS; Yoo NJ; Kim CS; Jang JJ; Chi JG; Zbar B; Lubensky IA; Linehan WM; Vortmeyer AO; Zhuang Z
    Cancer Res; 1998 Feb; 58(3):504-8. PubMed ID: 9458097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatic point mutation of the wild-type allele detected in tumors of patients with VHL germline deletion.
    Vortmeyer AO; Huang SC; Pack SD; Koch CA; Lubensky IA; Oldfield EH; Zhuang Z
    Oncogene; 2002 Feb; 21(8):1167-70. PubMed ID: 11850836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. von Hippel-Lindau gene deletion detected in the stromal cell component of a cerebellar hemangioblastoma associated with von Hippel-Lindau disease.
    Vortmeyer AO; Gnarra JR; Emmert-Buck MR; Katz D; Linehan WM; Oldfield EH; Zhuang Z
    Hum Pathol; 1997 May; 28(5):540-3. PubMed ID: 9158701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endolymphatic sac tumors. A source of morbid hearing loss in von Hippel-Lindau disease.
    Manski TJ; Heffner DK; Glenn GM; Patronas NJ; Pikus AT; Katz D; Lebovics R; Sledjeski K; Choyke PL; Zbar B; Linehan WM; Oldfield EH
    JAMA; 1997 May; 277(18):1461-6. PubMed ID: 9145719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Von Hippel-Lindau syndrome. A pleomorphic condition.
    Friedrich CA
    Cancer; 1999 Dec; 86(11 Suppl):2478-82. PubMed ID: 10630173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endolymphatic sac tumor with von Hippel-Lindau disease: report of a case with analysis of von Hippel-Lindau gene and review.
    Rao Q; Zhou J; Wang JD; Jin XZ; Ma HH; Lu ZF; Zhou XJ
    Ann Diagn Pathol; 2010 Oct; 14(5):361-4. PubMed ID: 20850701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatic mosaicism in von Hippel-Lindau Disease.
    Murgia A; Martella M; Vinanzi C; Polli R; Perilongo G; Opocher G
    Hum Mutat; 2000 Jan; 15(1):114. PubMed ID: 10612832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation of von Hippel-Lindau tumor suppressor gene in a sporadic endolymphatic sac tumor.
    Hamazaki S; Yoshida M; Yao M; Nagashima Y; Taguchi K; Nakashima H; Okada S
    Hum Pathol; 2001 Nov; 32(11):1272-6. PubMed ID: 11727270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Von Hippel-Lindau syndrome with spinal, cerebellar, and retinal hemangioblastoma in identical twins].
    Wessels T; Kemeny S; Block F
    Nervenarzt; 2002 Dec; 73(12):1195-8. PubMed ID: 12486572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Third International Meeting on von Hippel-Lindau disease.
    Zbar B; Kaelin W; Maher E; Richard S
    Cancer Res; 1999 May; 59(9):2251-3. PubMed ID: 10232616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. von Hippel-Lindau syndrome.
    Chou A; Toon C; Pickett J; Gill AJ
    Front Horm Res; 2013; 41():30-49. PubMed ID: 23652669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allelic deletions of the VHL gene detected in multiple microscopic clear cell renal lesions in von Hippel-Lindau disease patients.
    Lubensky IA; Gnarra JR; Bertheau P; Walther MM; Linehan WM; Zhuang Z
    Am J Pathol; 1996 Dec; 149(6):2089-94. PubMed ID: 8952541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.